<SEC-DOCUMENT>0001193125-22-170164-index.html : 20220608
<SEC-HEADER>0001193125-22-170164.hdr.sgml : 20220608
<ACCEPTANCE-DATETIME>20220608160110
ACCESSION NUMBER:		0001193125-22-170164
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20220608
DATE AS OF CHANGE:		20220608
EFFECTIVENESS DATE:		20220608

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immunovant, Inc.
		CENTRAL INDEX KEY:			0001764013
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				832771572
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-265477
		FILM NUMBER:		221003456

	BUSINESS ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		917-580-3099

	MAIL ADDRESS:	
		STREET 1:		320 WEST 37TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
		DATE OF NAME CHANGE:	20190108
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d342266ds8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: d342266ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d342266dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d342266dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d342266dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d342266dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d342266dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d342266dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g342266g0602042323501.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g342266g0602042323501.jpg

</DOCUMENT>
</SEC-DOCUMENT>